Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Frederic Colombel

Showing results (231-240 of 377) with videos related to

Pageof 38
Sort By:
Gastroenterology|November 10, 2021
Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled TrialsShomron Ben-Horin, Lena Novack, Ren Mao, et al.
Gastroenterology|December 12, 2018
No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel DiseasesRemi Mahmoud, Shailja C Shah, Joren R Ten Hove, et al.
Journal of Crohn'S & Colitis|November 12, 2023
The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b StudyBram Verstockt, Severine Vermeire, Laurent Peyrin-Biroulet, et al.
Gastroenterology|June 18, 2013
Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitisWilliam J Sandborn, Brian G Feagan, Colleen Marano, et al.
Digestive Diseases and Sciences|February 4, 2022
Breastfeeding Is Associated with Lower Likelihood of Helicobacter Pylori Colonization in Babies, Based on a Prospective USA Maternal-Infant CohortShailja C Shah, Leonid Tarassishin, Caroline Eisele, et al.
Journal of Crohn'S & Colitis|January 29, 2016
Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's DiseaseKarin Amcoff, Marie Joossens, Marie J Pierik, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2019
Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factorsManasi Agrawal, Shirley Cohen-Mekelburg, Maia Kayal, et al.
Gastroenterology|July 10, 2002
NOD2/CARD15 does not influence response to infliximab in Crohn's diseaseSeverine Vermeire, Edouard Louis, Paul Rutgeerts, et al.
Gastroenterology|March 31, 2018
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's DiseaseSilvio Danese, Stefanos Bonovas, Anthony Lopez, et al.
Digestive Diseases and Sciences|September 24, 2016
Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based StudyMathurin Fumery, Mathieu Kohut, Corinne Gower-Rousseau, et al.
Pageof 38

Showing results (231-240 of 377) with videos related to

Sort By:
Pageof 38
Gastroenterology|November 10, 2021
Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled TrialsShomron Ben-Horin, Lena Novack, Ren Mao, et al.
Gastroenterology|December 12, 2018
No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel DiseasesRemi Mahmoud, Shailja C Shah, Joren R Ten Hove, et al.
Journal of Crohn'S & Colitis|November 12, 2023
The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b StudyBram Verstockt, Severine Vermeire, Laurent Peyrin-Biroulet, et al.
Gastroenterology|June 18, 2013
Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitisWilliam J Sandborn, Brian G Feagan, Colleen Marano, et al.
Digestive Diseases and Sciences|February 4, 2022
Breastfeeding Is Associated with Lower Likelihood of Helicobacter Pylori Colonization in Babies, Based on a Prospective USA Maternal-Infant CohortShailja C Shah, Leonid Tarassishin, Caroline Eisele, et al.
Journal of Crohn'S & Colitis|January 29, 2016
Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's DiseaseKarin Amcoff, Marie Joossens, Marie J Pierik, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2019
Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factorsManasi Agrawal, Shirley Cohen-Mekelburg, Maia Kayal, et al.
Gastroenterology|July 10, 2002
NOD2/CARD15 does not influence response to infliximab in Crohn's diseaseSeverine Vermeire, Edouard Louis, Paul Rutgeerts, et al.
Gastroenterology|March 31, 2018
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's DiseaseSilvio Danese, Stefanos Bonovas, Anthony Lopez, et al.
Digestive Diseases and Sciences|September 24, 2016
Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based StudyMathurin Fumery, Mathieu Kohut, Corinne Gower-Rousseau, et al.
Pageof 38